Corneal Collagen Crosslinking
What is Corneal Collagen Crosslinking?
Keratoconus and corneal ectasia are degenerative conditions in which the cornea’s collagen weakens and begins to stretch outward and thin. Corneal weakening and thinning are caused by the collagen bonds breaking or stretching in the cornea. The weakened collagen alters the corneal shape and effects how the light enters the eye. This can result in blurred vision.
Crosslinking is a procedure which uses a combination of riboflavin eye drops (i.e. a type of vitamin B) and ultraviolet (UV) light to help strengthen the cornea from further weakening. The goal of crosslinking is to strengthen the corneal collagen bonds. A Crosslinking treatment does not reverse the blurred or distorted vision that has already occurred but attempts to prevent the vision from getting worse.
Prior to the Crosslinking treatment, a patient will need a complete eye exam to determine the severity of their keratoconus or corneal ectasia. Based on the exam, the doctor will determine if a crosslinking procedure is a viable treatment option. Crosslinking is a newly approved FDA procedure.
To schedule a complimentary consultation to see if you would qualify for LASIK, PRK, or a KAMRA Inlay please call (312) 300-5731, or use the button below. Please note, consultations are only complimentary for patients who haven’t had a LASER procedure done before on their eyes. All other appointments are billed to your major medical insurance.
Please check with your insurance provider to see if our doctors are in your network.